Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnon Adler

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Heart Failure|August 2, 2024
Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathyFernando L Scolari, Darshan Brahmbhatt, Sagi Abelson, et al.
JACC. Clinical Electrophysiology|March 6, 2026
Genotype and Family History as Risk Markers of Sudden Cardiac Death in Hypertrophic CardiomyopathyAli Sakhnini, Mahdi Montazeri, Cindy Chow, et al.
Circulation. Arrhythmia and Electrophysiology|June 15, 2021
Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF ScoreRichard T Carrick, Martin S Maron, Arnon Adler, et al.
Circulation. Arrhythmia and Electrophysiology|October 15, 2014
Long QT syndrome complicating atrioventricular block: arrhythmogenic effects of cardiac memoryRaphael Rosso, Arnon Adler, Boris Strasberg, et al.
Journal of the American College of Cardiology|April 16, 2013
Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countriesSami Viskin, Arthur A M Wilde, Milton E Guevara-Valdivia, et al.
Circulation. Population Health and Outcomes|April 30, 2026
Family Members' Experiences Communicating With Coroners in Suspected Hereditary Sudden Cardiac Death Cases: A Mixed Methods Study in CanadaKatherine S Allan, Katherine L Mason, Ariel Gershon, et al.
Nature Communications|April 13, 2016
A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillationNathan Orr, Rima Arnaout, Lorne J Gula, et al.
The Canadian Journal of Cardiology|June 16, 2024
Canadian Cardiovascular Society Clinical Practice Update on Contemporary Management of the Patient With Hypertrophic CardiomyopathyAndrew M Crean, Arnon Adler, Laura Arbour, et al.
Heart Rhythm|February 4, 2012
The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndromeArnon Adler, Christian van der Werf, Pieter G Postema, et al.
Heart Rhythm|December 21, 2021
Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter studyEthan J Rowin, Martin S Maron, Arnon Adler, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Heart Failure|August 2, 2024
Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathyFernando L Scolari, Darshan Brahmbhatt, Sagi Abelson, et al.
JACC. Clinical Electrophysiology|March 6, 2026
Genotype and Family History as Risk Markers of Sudden Cardiac Death in Hypertrophic CardiomyopathyAli Sakhnini, Mahdi Montazeri, Cindy Chow, et al.
Circulation. Arrhythmia and Electrophysiology|June 15, 2021
Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF ScoreRichard T Carrick, Martin S Maron, Arnon Adler, et al.
Circulation. Arrhythmia and Electrophysiology|October 15, 2014
Long QT syndrome complicating atrioventricular block: arrhythmogenic effects of cardiac memoryRaphael Rosso, Arnon Adler, Boris Strasberg, et al.
Journal of the American College of Cardiology|April 16, 2013
Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countriesSami Viskin, Arthur A M Wilde, Milton E Guevara-Valdivia, et al.
Circulation. Population Health and Outcomes|April 30, 2026
Family Members' Experiences Communicating With Coroners in Suspected Hereditary Sudden Cardiac Death Cases: A Mixed Methods Study in CanadaKatherine S Allan, Katherine L Mason, Ariel Gershon, et al.
Nature Communications|April 13, 2016
A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillationNathan Orr, Rima Arnaout, Lorne J Gula, et al.
The Canadian Journal of Cardiology|June 16, 2024
Canadian Cardiovascular Society Clinical Practice Update on Contemporary Management of the Patient With Hypertrophic CardiomyopathyAndrew M Crean, Arnon Adler, Laura Arbour, et al.
Heart Rhythm|February 4, 2012
The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndromeArnon Adler, Christian van der Werf, Pieter G Postema, et al.
Heart Rhythm|December 21, 2021
Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter studyEthan J Rowin, Martin S Maron, Arnon Adler, et al.
Pageof 8